Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02501343Completed
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and dysglycemia (2 arms), sponsored by Garvan Institute of Medical Research. Primary endpoint: Changes in venous blood pH at 3 hours. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02501343.